




 |
  |
| |
|
| |
Short
Telomeres in Patients with Vascular Dementia: An Indicator of Low Antioxidative
Capacity and a Possible Risk Factor?
|














|
|
Thomas von Zglinicki,
Violeta Serra, Mario Lorenz, Gabriele Saretzki, Romana Lenzen-Grobimlighaus,
Reinhard Gebner, Angela Risch, and Elisabeth
Steinhagen-Thiessen
|
| |
|
| |
Institute
of Pathology (TvZ, VS, ML, GS), Research Group Geriatrics (RL-G, ES-T) at
the Evangelische Geriatriezentrum Berlin, and Institute of Laboratory Medicine
and Pathobiochemistry (RG), Charité, Humboldt University, Berlin,
and Department of Toxicology and Cancer Risk Factors (AR), German Cancer
Research Center, Heidelberg, Germany
|
| |
|
| |
Progressive cerebrovascular atherosclerosis and consecutive stroke are
among the most common causes of dementia. However, specific risk factors
for vascular dementia are still not known. Human telomeres shorten with
each cell division in vitro and with donor age in vivo. In human fibroblasts
in vitro, the telomere shortening rate decreased with increasing antioxidative
capacity. There was a good intra-individual correlation between the age-corrected
telomere lengths in fibroblasts and peripheral blood mononuclear cells.
In 186 individuals including 149 geriatric patients (age range, 55-98
yr), leukocyte telomeres in patients with probable or possible vascular
dementia were significantly shorter than in three age-matched control
groups, namely in cognitively competent patients suffering from cerebrovascular
or cardiovascular disease alone, in patients with probable Alzheimer's
dementia, and in apparently healthy control subjects. No correlation was
found to polymorphisms in the apolipoprotein E and glutathione-S-transferase
genes. Telomere length may be an independent predictor for the risk of
vascular dementia.
|
| |
|
| |
 |